ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications

January 31, 2014

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003